NCT01557283View on ClinicalTrials.gov

An Observational Study of the Real Life Management of the Psoriasis Patients Treated With Enbrel According to the New Reimbursement Criteria

CompletedOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Plaque Psoriasis Patients
Interventions
OTHER

Enbrel treatment

Enbrel SC 50mg once weekly or 25mg twice weekly

Trial Locations (1)

3000

Herestraat 49, Leuven

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01557283 - An Observational Study of the Real Life Management of the Psoriasis Patients Treated With Enbrel According to the New Reimbursement Criteria | Biotech Hunter | Biotech Hunter